Skip to content
TrialScanner

NCT02238626

Ibudilast (MN-166) in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Phase 2CompletedMNOVLead

Registry record

Lead sponsor
MediciNova
Conditions
Amyotrophic Lateral Sclerosis
Primary completion
Aug 2017Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02238626 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02238626: Ibudilast (MN-166) in... | TrialScanner